Pre-IPO Xiamen Yan Palace Bioengineering (PHIP Updates) - Some Points Worth the Attention
As Yan palace's revenue growth further declines, effectiveness of marketing activities has already decrease. Huge selling expenses erode profit...
Pre-IPO Xiamen Yan Palace Bioengineering - Concerns About Profitability and Growth Sustainability
Since the efficacy/actual value of EBN is questionable, marketing/promotion alone cannot drive future performance growth.Yan Palace's profit model...
ECM Weekly (25th June 2023) - Tryt, Shiyue Daotian, Keep, SML, HDFC, Shriram, Tata Tech, Doosan, J&T
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
Keep Pre-IPO - Updates Since Our Last Note - Losses Have Been the Only Constant
Keep Inc (KEEP HK) is looking to raise around US$100m in its upcoming Hong Kong IPO. In this note, we discuss the updates since our last note.
Xiamen Yan Palace Bioengineering Pre-IPO Tearsheet
Xiamen Yan Palace Bioengineering (1951686D CH) is looking to raise around US$200m in its upcoming Hong Kong IPO. The deal will be run by CICC and...
No more insights